News
Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U ...
Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...
Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...
Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.
The FDA’s new policy limits COVID-19 vaccine eligibility to older adults and high-risk groups, excluding millions from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results